A study published in September 2017, titled: ‘Quality of life after brachytherapy or bilateral nerve‐sparing robot‐assisted radical prostatectomy for prostate cancer: a prospective cohort’, compared patient quality of life after either brachytherapy or radical prostatectomy treatments.
New guidelines around PSA testing promise to transform prostate cancer outcomes in Australia. The guidelines, which recommend that asymptomatic men between the ages of 50-69 are offered PSA testing every two years1, replace US Preventative Services Task Force guidelines and previous differing guidelines in Australia that some urologists blame for an increase in presentations with metastatic prostate cancer2. Certainly, when screening was discouraged, adverse consequences followed, with evidence showing that mortality from prostate cancer is lower when men are screened for it3. With prostate ca...
BXTAccelyon, the leading low dose rate (LDR) brachytherapy partner to hospitals and clinics worldwide and the sole distribution partner outside North America for the new PrecisionPoint™ Transperineal Access System, announces its availability to the Australian healthcare market. The new medical device, which has recently received TGA approval, offers urologists a safer and more accurate method to diagnose potential incidents of prostate cancer.
BXTAccelyon is pleased to announce that its Benelux, LDR Brachytherapy conference taking place on the 27th January 2018 at the Museum Aan De Stroom, Antwerp has been endorsed by the scientific organisation of radiation oncology in Belgium (ABRO/BVRO).
Prostate cancer is the most common form of cancer in men, and will directly or indirectly effect most of us in our lifetime. With new research showing that half of prostate cancer patients undergo treatment without knowing their treatment options, it is more important than ever to talk openly about this disease and the full range of choices available when deciding upon treatment.
Jeremy Hunt has affirmed his support for an appeal to raise £2 million towards the construction of a world-class NHS Urology Centre at the Royal Surrey County Hospital.
Everyone who buys a brick for £10 will have their name recorded in a book of appreciation in the new centre reception. BXTAccelyon will be donating £250 towards the project.
New Zealand brachytherapy patient and prostate cancer survivor, Bruce Stewart, recently shared his story with Fairfax Media New Zealand – see his story here, and a detailed case study of Bruce’s experience with brachytherapy below.
A prostate cancer procedure on the Thursday, golf on Friday, about sums up Palmerston North solicitor and prostate cancer survivor Bruce Stewart’s experience with Low Dose Rate (LDR) brachytherapy.
More men in Northern Ireland are surviving prostate cancer thanks to the latest advances in treatment being carried out by specialists in Belfast with the support of the Belfast Health and Social Care Trust and local charity Friends of the Cancer Centre.
Prostate cancer is the most common cancer in men in the UK, and arguably the most intimate too, which can cause some patients to feel embarrassed when it comes to discussing their symptoms or treatment options with a specialist. This Prostate Cancer Awareness Month, with diagnoses on the rise, it’s more important than ever that men feel confident in discussing their condition and empowered to seek all the possible treatment options – some of which offer far better long term outcomes in both sexual function and continence.